ARID1A and neoplasm: We observed that ARID1A-mutated GI cancers showed significantly higher TMB (defined as the total number of somatic mutations in tumor) than ARID1A-wildtype GI cancers (Mann-Whitney U test, P < 0.001) (Figure 2A).